Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license
Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
Politics & Law Vietnamese leader visits Ireland's National Institute for Bioprocessing Research & Training
Politics & Law Prime Minister reflects on General Secretary Nguyễn Phú Trọng's contributions to Việt Nam's development
Media-OutReach Newswire AIM Vaccine submitted the pre-application for clinical trials for novel-process highly-effective human diploid rabies vaccine